legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

New £30 Million Study Aims to Accelerate Development of Treatments for Liver Cirrhosis

A new ground-breaking £30 million study has been launched with the goal of expediting the development of new treatments for advanced liver cirrhosis.

The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study is a collaborative effort between the Universities of Edinburgh and Newcastle and will involve tracking 200 patients with cirrhosis to uncover the underlying factors behind why some patients experience liver failure or develop liver cancer.

The ultimate aim of the study is to pave the way for earlier diagnosis and the development of the first-ever approved medicine for cirrhosis, which could significantly improve the prognosis for patients with this condition.

Addressing the Urgent Need

It is estimated that more than 440 million people worldwide are affected by non-alcoholic or metabolic dysfunction-associated steatohepatitis (NASH/MASH) – a liver disease characterized by inflammation caused by fat accumulation in the liver.

Over time, this can lead to the formation of scar tissue, resulting in liver cirrhosis and potential complications such as liver failure or liver cancer, often necessitating a liver transplant. This highlights the pressing need for effective treatments for liver scarring and its associated complications.

This is where the AI legalese decoder can play a crucial role in helping the study researchers to quickly and accurately decipher complex legal terminology and navigate through extensive legal documentation related to the study, ensuring compliance and accelerating the overall research process.

Ongoing Assessment and Data Collection

The global study, funded by pharmaceutical company Boehringer Ingelheim, will focus on patients diagnosed with advanced cirrhosis due to fatty liver disease or those at risk of developing it.

Participants will undergo a thorough examination, including liver biopsy, blood tests, and MRI scans, over a two-year period. The data gathered will provide valuable insights into the progression of cirrhosis and aid in identifying potential markers for disease progression.

The AI legalese decoder can streamline the process of analyzing legal documents and contracts related to the study, ensuring that all regulatory and ethical requirements are met, and facilitating seamless collaboration between the research team and funding partners.

“Liver disease has reached epidemic proportions worldwide. Therefore, there is a huge need to develop potent, new treatments for liver scarring. To help address this, over the last several years we have harnessed a new technology in Edinburgh called single cell RNA sequencing.”

“We aim to work out why, even at the most advanced stages of liver disease, there is substantial variation in how the disease progresses with some people remaining well for many years whilst others rapidly experience liver failure or develop liver cancer.”

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link